Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Hungarys National Centre for Public Health and Pharmacy (NNGYK) has downplayed the current respiratory season as a ...

Hospitals in China have been 'overwhelmed' by outbreak says WHO as NHS says people with respiratory symptoms should 'limit ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...

Outpatient health care visits for flu-like illnesses are at their highest levels in 15 years, according to data updated ...

Respiratory ... syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first ...

Discovered first in the Netherlands in 2001, it’s part of the same viral family as RSV, known officially as respiratory syncytial virus ... a peak at this time of year. Infections are usually ...

Outlook on RSV, COVID-19 and flu in Canada: Rates of respiratory syncytial virus ... the risk to humans will increase as the virus mutates. A 13-year-old girl from B.C. was the first – and ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.